Difference between revisions of "DZI20-138-Case-17"
From MGH Learn Pathology
(Automatic edit to upgrade to new templates) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 11: | Line 11: | ||
|supportingInfo=Invasive adenocarcinoma with high-grade malignancy ?PNET (permanent dx: small cell carcinoma (neuroendocrine type) in a background of invasive endometrioid adenocarcinoma, grade 1 of 3). | |supportingInfo=Invasive adenocarcinoma with high-grade malignancy ?PNET (permanent dx: small cell carcinoma (neuroendocrine type) in a background of invasive endometrioid adenocarcinoma, grade 1 of 3). | ||
|reasonCode=67 yo F with atypical endometrial hyperplasia on biopsy | |reasonCode=67 yo F with atypical endometrial hyperplasia on biopsy | ||
| − | |subject= | + | |subject=MGH |
| − | |performer= | + | |performer=NS495 |
|sequence=17 | |sequence=17 | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 32: | Line 33: | ||
|identifier=DZI20-138-Case-17_2 | |identifier=DZI20-138-Case-17_2 | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Abw33 | ||
| + | |authoredOn=2025-10-24T13:26:58.460235+00:00 | ||
}} | }} | ||
Latest revision as of 08:26, October 24, 2025
